Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Upper Facial Lines in Japan
NCT01797094Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2013
- Primary completion
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of onabotulinumtoxinA in facial rhytides, glabellar lines, periorbital wrinkles, sponsored by Allergan. Started Feb 2013; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
facial rhytidesglabellar linesperiorbital wrinkles
Beyond the preview
Go deeper on NCT01797094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797094.